Edition:
India

Aslan Pharmaceuticals Ltd (ASLN.OQ)

ASLN.OQ on NASDAQ Stock Exchange Global Market

1.86USD
17 Sep 2019
Change (% chg)

$-0.09 (-4.62%)
Prev Close
$1.95
Open
$1.92
Day's High
$1.98
Day's Low
$1.86
Volume
1,890
Avg. Vol
5,671
52-wk High
$8.07
52-wk Low
$1.50

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Mar '19 92.36 -0.835
FY 2018 Dec '18 0.00 -2.144
Sep '18 0.00 -2.134
Jun '18 0.00 -2.233
Mar '18 0.00 -1.959
FY 2017 Dec '17 0.00 -3.358
Sep '17 0.00 -1.851
Jun '17 0.00 -2.299
Mar '17 0.00 -2.169
 
*Note: Units in Millions ofTaiwanese Dollars
**Note: Units in Taiwanese Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 29.73 33.85
P/E High - Last 5 Yrs. -- 47.56 54.29
P/E Low - Last 5 Yrs. -- 27.30 28.22
Beta -- 1.00 0.99
Price to Sales (TTM) 35.22 6.00 7.90
Price to Book (MRQ) 4.01 3.84 4.38
Price to Tangible Book (MRQ) 32.83 4.14 5.07
Price to Cash Flow (TTM) -- 21.62 23.70
% Owned Institutions -- 0.79 1.78

Dividends

  Company industry sector
Dividend Yield -- 1.83 1.67
Dividend Yield - 5 Year Avg -- 1.47 1.37
Dividend 5 Year Growth Rate -- 6.74 6.82
Payout Ratio(TTM) -- 50.64 46.67

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 13.42 14.65
Sales (TTM) vs TTM 1 Yr. Ago -- 6.45 8.45
Sales - 5 Yr. Growth Rate -- 8.32 9.43
EPS (MRQ) vs Qtr. 1 Yr. Ago 57.40 18.49 19.40
EPS (TTM) vs TTM 1 Yr. Ago 22.41 -- --
EPS - 5 Yr. Growth Rate -- 5.66 7.15
Capital Spending - 5 Yr. Growth Rate 74.60 7.02 8.01

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.52 2.52
Current Ratio (MRQ) 3.80 3.55 3.52
LT Debt to Equity (MRQ) 53.94 11.64 12.61
Total Debt to Equity (MRQ) 54.79 16.17 17.64
Interest Coverage (TTM) -47.14 7.61 14.93

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 96.67 51.41 50.25
Gross Margin - 5 Yr. Avg. -- 50.53 51.36
EBITD Margin (TTM) -1,232.14 -- --
EBITD - 5 Yr. Avg -- 17.64 16.42
Operating Margin (TTM) -1,242.12 -2.19 -6.97
Operating Margin - 5 Yr. Avg. -- 13.94 11.87
Pre-Tax Margin (TTM) -1,244.30 -2.50 -7.30
Pre-Tax Margin - 5 Yr. Avg. -- 18.73 15.72
Net Profit Margin (TTM) -1,244.87 -6.21 -11.11
Net Profit Margin - 5 Yr. Avg. -- 14.06 11.11
Effective Tax Rate (TTM) -- 20.27 20.61
Effective Tax Rate - 5 Yr. Avg. -- 22.92 24.51

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 1,012,949,194 870,638,159
Net Income/Employee (TTM) -- 118,477,208 101,855,832
Receivable Turnover (TTM) 5.99 5.61 5.88
Inventory Turnover (TTM) -- 2.59 3.66
Asset Turnover (TTM) 0.06 0.88 0.85

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -77.61 10.57 10.25
Return on Assets - 5 Yr. Avg. -- 11.70 11.17
Return on Investment (TTM) -98.11 13.04 12.69
Return on Investment - 5 Yr. Avg. -- 14.80 14.15
Return on Equity (TTM) -144.36 14.12 17.13
Return on Equity - 5 Yr. Avg. -- 15.92 15.53
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 12.61 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Aslan Pharmaceuticals Ltd

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 1.82%
# of Holders: 3
Total Shares Held: 2,914,062
3 Mo. Net Change: -18,238
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 0
# Reduced Positions: 1
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.